Carlsbad / Burlingame / Alabaster / Boston / Palo Alto / Pelham / Winchester / Alto / St Louis / Billerica / Kim / ZHANG ET / Cambridge / Holtsville / Rockford / Torrance / /
Company
Brookhaven Instruments Corporation / Agency for Science / Millipore / Sigma-Aldrich / Agilent / Vector Laboratory Inc. / assayed using an Agilent / /
Country
United States / Korea / Singapore / /
Currency
USD / / /
Event
FDA Phase / Judicial Event / /
Facility
Brigham Women’s Hospital / Laboratory of Nanomedicine / Massachusetts Institute / Massachusetts Institute of Technology / /
IndustryTerm
nanoparticle-based therapeutic products / plasma solution / breast cancer therapy / imaging / heparin solution / human plasma solution / drug carrier / ethanol aqueous solution / Treatment of Multidrug-Resistant Breast Cancer / acetonitrile solution / prewarmed fresh media / preheated lipid solution / /
MedicalCondition
Multidrug-Resistant Breast Cancer / metastatic breast cancer / PC3 prostate adenocarcinomas / prostate cancer / Cancer / Sarcoma / LNCaP prostate adenocarcinomas / /
MedicalTreatment
drug carrier / breast cancer therapy / drug carriers / dialysis / /
Organization
Harvard Medical School / Food and Drug Administration / PLGA / Department of Biology / Massachusetts Institute of Technology / Division of Health Science and Technology / Brigham Women’s Hospital / Department of Anesthesiology / Laboratory of Nanomedicine and Biomaterials / Department of Chemical Engineering / American Chemical Society / National Park Service / NP PBS / EB003647 and David Koch-Prostate Cancer Foundation / NHS / Agency for Science / Technology and Research / /
Person
Robert Langer / Ward Hill / Nat / Frank X. Gu / Frank Alexis / David Koch-Prostate / Andrew Z. Wang / Neil Bander / Dtxl / Pegylated-Liposomal Doxorubicin / Omid C. Farokhzad / Torchilin / V / Aleksandar F. Radovic-Moreno / Philip Kantoff / /